Global Advanced Visualization Market Size Study & Forecast, by Product and Service (Hardware, Software, Services), By Type of Solution (Enterprise, Standalone), By Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, N

Global Advanced Visualization Market Size Study & Forecast, by Product and Service (Hardware, Software, Services), By Type of Solution (Enterprise, Standalone), By Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Medicine, Other Imaging Modalities), By Clinical Application (Oncology, Orthopedics, Cardiovascular, Neurology, Other Clinical Applications), and Regional Analysis, 2023-2030

Global Advanced Visualization Market is valued approximately at USD XX billion in 2022 and is anticipated to grow with a growth rate of more than 11.3% over the forecast period 2023-2030. Advanced visualization systems are sophisticated medical devices incorporating advanced software to efficiently display multiple aspects of living cells. They significantly reduce the time clinicians need to report results to patients and find extensive use in pathology laboratories across various clinical applications. Advanced visualization is used in healthcare to create detailed 3D visual representations of medical images such as CT scans and MRI scans. These tools help healthcare professionals analyze and interpret imaging data more effectively by providing comprehensive views of anatomical structures and physiological processes. Advanced visualization includes features such as multi-planar reconstruction, volume rendering, virtual endoscopy, surface rendering, and fusion imaging, enhancing diagnostic accuracy and treatment planning across various medical specialties. The global advanced visualization market is propelled by factors such as a growing prevalence of chronic diseases, growing aging population, soaring demand for efficient and early diagnosis, and increased awareness about the benefits of advanced visualization tools in disease detection.

In addition, the prevalence of chronic diseases such as cancer, heart disease, and diabetes is increasing. Advanced visualization tools are crucial for improved diagnostics and treatment planning in such cases. Based on data from the World Health Organization (WHO) released in April 2021, chronic diseases are projected to cause 41 million deaths annually, comprising 71% of global mortality. In low- and middle-income nations, these diseases are responsible for 77% of all deaths. Among chronic diseases, cardiovascular conditions lead to the highest mortality, claiming approximately 17.9 million lives yearly, followed by cancer (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). The market is growing because advanced visualization platforms are essential for disease identification, treatment planning, and monitoring. Moreover, the rise in the technological advancement in software and technology, as well as the incorporation of AV solutions in mobile devices presents various lucrative opportunities over the forecast years. However, market growth is hindered by limited reimbursement for radiology-based diagnostic procedures and technological constraints associated with existing advanced visualization systems.

The key regions considered for the Global Advanced Visualization Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the rising cases of chronic illnesses and improved healthcare infrastructure. Additionally, the rising geriatric population is resulting in the prevalence of chronic diseases in the region, which, in turn, accelerates the market growth throughout the estimated period of 2023-2030. Furthermore, the market experiences growth due to recent advancement, approvals, and advanced visualization platforms launches. For instance, in November 2021, LifeVoxel.AI, a San Diego-based medical platform specializing in AI and Visualization, secured USD 5 million in seed funding. LifeVoxel's patented technologies enable immediate and seamless access to interactive imaging studies and data, with zero latency and no client footprint, delivering them in high-quality 4K resolution. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rising burden of chronic diseases, growing public awareness regarding the benefits of advanced visualization, coupled with the increasing government initiative to promote innovation and adoption of advanced technologies in healthcare are significantly propelling the market demand across the region.

Major market players included in this report are:
Agfa-Gevaert Group
Canon Inc. (Canon Medical Systems Corporation)
Carestream Health
Fujifilm Holdings Corporation
General Electric Company (GE Healthcare)
Koninklijke Philips NV
Pro Medicus Ltd
Siemens Healthcare GmbH
Terarecon Inc.
Visage Imaging, Inc.

Recent Developments in the Market:
 In February 2022, Siemens Healthineers and Universal Medical Imaging entered into a collaboration aimed at enhancing the efficiency of image screening and disease diagnosis for primary healthcare institutions in China. This collaboration leverages advanced imaging diagnostic equipment from Siemens Healthineers along with remote scanning assistant tools provided by Universal Medical Imaging, harnessing the expertise of medical imaging professionals nationwide.
 In August 2022, Kitware unveiled MIQA, an innovative cloud-based application designed for medical image quality assurance. This platform enables seamless collaboration and supports longitudinal studies among teams dispersed across different geographic locations.

Global Advanced Visualization Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Product and Service, Type of Solution, Imaging Modality, Clinical Application, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product and Service:
Hardware
Software
Services

By Type of Solution:
Enterprise
Standalone

By Imaging Modality:
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Ultrasound
Nuclear Medicine
Other Imaging Modalities

By Clinical Application:
Oncology
Orthopedics
Cardiovascular
Neurology
Other Clinical Applications.

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.